Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MC-1-50 CAR-T in refractory systemic lupus erythematosus
NCT06892145Phase 1Recruiting
- Sponsor
- Chongqing Precision Biotech
- Start
- Jun 2025
- Primary completion
- May 2026
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of PTOC1 in systemic lupus erythematosus (SLE), sponsored by Chongqing Precision Biotech. Primary endpoint: Adverse Events at 1 month. Started Jun 2025; status: recruiting.
02
Drugs
PTOC1
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT06892145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06892145.